saplin

Compare funds

SBI MultiCap vs HDFC Multi Cap

Both are multi cap funds. Over the last 3 years SBI MultiCap returned 13.7% a year and HDFC Multi Cap 12.0%, against a category median of 15.1%. SBI MultiCap costs 1.04% a year and HDFC Multi Cap 0.95%. On the saplin Score SBI MultiCap rates 5.7 (Weak) and HDFC Multi Cap 4.7 (Weak) within their category. 21.1% of their money is in the same stocks.

Direct plans, growth option. Returns and risk as of 15 Nov 2026; past performance does not tell you future returns. See both side by side with charts.

At a glance

SBI MultiCapHDFC Multi CapCategory median
saplin Score (0–10)5.7 Weak4.7 Weak—
1-year return1.7%-1.3%6.2%
3-year return, a year13.7%12.0%15.1%
5-year return, a year——13.4%
Volatility (standard deviation)14.7%16.8%16.8%
Sharpe ratio0.500.390.56
Beta0.830.980.94
Upside capture8797104
Downside capture7710295
Expense ratio (Direct)1.04%0.95%0.95%
Fund size₹24,132 cr₹20,439 cr₹3,488 cr
Number of holdings7111778
Top 10 holdings, share of fund28.9%25.3%27.0%
Portfolio P/E33.925.928.7
Lead managerRuchit Mehta (1 yr)Amar Kalkundrikar (1 yr)—
Launched8 Mar 202210 Dec 2021—

Green marks the higher return, Sharpe ratio, upside capture and Score, and the lower volatility, downside capture and cost. That is the direction of each measure, not a recommendation.

Portfolio overlap

SBI MultiCap and HDFC Multi Cap have 21.1% of their portfolios in the same stocks (21 holdings in common, portfolios as of 31 Oct 2026). Overlap is the smaller of the two weights in each shared holding, added up: 100% would be identical portfolios.

Biggest shared holdingsSBI MultiCapHDFC Multi Cap
ICICI Bank4.28%3.96%
HDFC Bank3.03%3.92%
Kotak Mahindra Bank2.53%2.17%
Maruti Suzuki India1.30%1.19%
Sona BLW Precision Forgings1.95%1.17%
Eternal1.08%2.34%
Coforge1.90%1.07%
Divi's Laboratories3.64%0.96%
Jubilant Foodworks1.86%0.95%
Blue Star1.79%0.92%

The funds

How the Score works: methodology. Check any set of funds with the overlap checker.

More comparisons

saplin is not registered with SEBI. This page compares published data and is not a recommendation to buy, hold or sell either fund.